Stock 6568 KNC LABORATORIES CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

News KNC Laboratories Co., Ltd.

Equities

6568

JP3290400005

Delayed Japan Exchange
Other stock markets
 09:00:17 2024-04-29 pm EDT 		5-day change 1st Jan Change
1,403 JPY +0.36% Intraday chart for KNC Laboratories Co., Ltd. +0.94% -3.44%
Mar. 14 KNC Laboratories Co., Ltd. acquired an unknown stake in NapaJen Pharma, Inc. from INCJ, Ltd. CI
2022 Tranche Update on KNC Laboratories Co., Ltd.'s Equity Buyback Plan announced on May 13, 2022. CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
KNC Laboratories Co., Ltd. acquired an unknown stake in NapaJen Pharma, Inc. from INCJ, Ltd.
CI
Tranche Update on KNC Laboratories Co., Ltd.'s Equity Buyback Plan announced on May 13, 2022.
CI
KNC Laboratories Co., Ltd.'s Equity Buyback announced on May 13, 2022, has closed with 100,000 shares, representing 1.29% for ¥111.5 million.
CI
KNC Laboratories Co., Ltd. announces an Equity Buyback for 100,000 shares, representing 1.29% for ¥111.5 million.
CI
KNC Laboratories Co., Ltd. authorizes a Buyback Plan.
CI
Certain Common Shares of KNC Laboratories Co., Ltd. are subject to a Lock-Up Agreement Ending on 10-SEP-2018.
CI
KNC Laboratories Co., Ltd. has completed an IPO in the amount of ¥5.30712 billion.
CI
KNC Laboratories Co., Ltd. has filed an IPO.
CI
Kobe University, Knc Laboratories Co.,Ltd., and Dainippon Sumitomo Pharma Co., Ltd. Signs License Agreement and Joint Research Agreement
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 6568 Stock
  4. News KNC Laboratories Co., Ltd.